Search

5 June 2025 - The Active ingredient prescribing (AIP) initiative helps ensure consistent information about prescription medicines is used when health practitioners prescribe and dispense medicines for their patients.

9 April 2024 - Find out how we define and monitor cases of HPV, how you can get vaccinated, and where you can learn more about this disease.

11 April 2025 - Find out how we define and monitor cases of psittacosis (also called ornithosis), and where you can learn more about this disease.

17 June 2025 - Active ingredient prescribing (AIP) is part of a wider government initiative to ensure the safe prescribing and dispensing of prescription medicines. Learn more about the program and why it is important.

1 January 2026 - The Medical Treatment Overseas Program (MTOP) helps approved Australians who have a life-threatening medical condition access life-saving medical treatment overseas where treatment is not available in Australia.

16 June 2025 - This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 6 products from the current product range of Omnigon BBraun Flexima Active (SAS Code 80165F) in subgroup 3(b) of the Stoma Appliance Scheme (SAS) Schedule.

13 February 2026 - Eating disorders affect many Australians and can be life threatening. Recovery can be hard, but it is possible with the right care. We are working with state and territory governments and the eating disorders sector to improve access to affordable and evidence-based eating disorder support and care.

17 June 2025 - Learn about what is, and what is not an active ingredient in prescription medicines.

17 June 2025 - Active ingredient prescribing (AIP) is mandatory for most prescription medications listed on the Pharmaceutical Benefits Schedule (PBS) and the Repatriation Schedule of Pharmaceutical Benefits (RPBS).

3 October 2025 - This outcomes register is a record of the Active Ingredient Prescribing Working Group (AIPWG) review of specific medicines from 1 January 2023.